BRYGZU Trademark
Trademark Overview
On Wednesday, June 19, 2024, a trademark application was filed for BRYGZU with the United States Patent and Trademark Office. The USPTO has given the BRYGZU trademark a serial number of 98608119. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, November 26, 2024. This trademark is owned by Eli Lilly and Company. The BRYGZU trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative co...
General Information
Serial Number | 98608119 |
Word Mark | BRYGZU |
Filing Date | Wednesday, June 19, 2024 |
Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
Status Date | Tuesday, November 26, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, October 1, 2024 |
Trademark Statements
Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, June 19, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Eli Lilly and Company |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Indianapolis, IN 46285 |
Party Name | Eli Lilly and Company |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Indianapolis, IN 46285 |
Trademark Events
Event Date | Event Description |
Wednesday, June 19, 2024 | NEW APPLICATION ENTERED |
Wednesday, June 19, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, August 27, 2024 | ASSIGNED TO EXAMINER |
Tuesday, August 27, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, September 11, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, October 1, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, October 1, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, November 26, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |